Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Concert Pharmaceuticals
With
Cognitive Research Corporation
Age
18–55
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Physician confirmed diagnostic and statistical manual-version 5 (DSM-V5) diagnosis of schizophrenia for the past 2 years
Patients with clinically stable schizophrenia with residual symptoms defined as positive and negative syndrome scale (PANSS) total score of 70-110
Patients currently treated with one antipsychotic medication
You may not be if
Patients who, in the opinion of the Investigator, have a history of antipsychotic treatment resistance
Patients currently taking clozapine
History of meeting DSM-V5 criteria for moderate to severe alcohol or substance use disorder (other than nicotine or caffeine) within the 6 months before the first Screening Visit
Patients with positive blood screen for human immunodeficiency virus (HIV) antibody and/or hepatitis B virus surface antigen
Patients with history of renal disease or those taking medications to treat renal disease
